[1]
|
IDF (2021) IDF Diabetes Atlas. 10th Edition. http://www.diabetesatlas.org
|
[2]
|
李嘉欣, 马婷婷, 南一, 等. 糖尿病肾病发病机制研究进展[J]. 临床肾脏志, 2019, 19(11): 860-864.
|
[3]
|
Xie, C., Wu, W., Tang, A., Luo, N. and Tan, Y. (2019) lncRNA GAS5/miR-452-5p Reduces Oxidative Stress and Pyroptosis of High-Glucose-Stimulated Renal Tubular Cells. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 12, 2609-2617. https://doi.org/10.2147/DMSO.S228654
|
[4]
|
Zhang, Z., et al. (2018) Caspase-11-Mediated Tubular Epithelial Py-roptosis Underlies Contrast-Induced Acute Kidney Injury. Cell Death & Disease, 9, 983. https://doi.org/10.1038/s41419-018-1023-x
|
[5]
|
Nagata, M. (2016) Podocyte Injury and Its Consequences. Kidney International, 89, 1221-1230.
https://doi.org/10.1016/j.kint.2016.01.012
|
[6]
|
Cheng, Q., et al. (2020) Caspase-11/4 and Gasdermin D-Mediated Pyroptosis Contributes to Podocyte Injury in Mouse Diabetic Nephropathy. Acta Pharmacologica Sinica, 42, 954-963. https://doi.org/10.1038/s41401-020-00525-z
|
[7]
|
Correa-Oliveira, R., Fachi, J.L., Vieira, A., et al. (2016) Regula-tion of Immune Cell Function by Short-Chain Fatty Acids. Clinical & Translational Immunology, 5, e73. https://doi.org/10.1038/cti.2016.17
|
[8]
|
Matijasic, M., Mestrovic, T., Paljetak, H.C., Peric, M., Baresic, A. and Verbanac, D. (2020) Gut Microbiota beyond Bacteria-Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD. International Journal of Molecular Sciences, 21, 2668. https://doi.org/10.3390/ijms21082668
|
[9]
|
Jayasudha, R., Das, T., Kalyana Chakravarthy, S., Sai Prashanthi, G., Bhargava, A., Tyagi, M., Rani, P.K., Pappuru, R.R. and Shivaji, S. (2020) Gut Mycobiomes Are Altered in People with Type 2 Diabetes Mellitus and Diabetic Retinopathy. PLOS ONE, 15, e0243077. https://doi.org/10.1371/journal.pone.0243077
|
[10]
|
Kieffer, D.A., Piccolo, B.D., Vaziri, N.D., Liu, S., Lau, W.L., Khazaeli, M., Nazertehrani, S., Moore, M.E., Marco, M.L., Martin, R.J., et al. (2016) Resistant Starch Alters Gut Microbiome and Metabolomic Profiles Concurrent with Amelioration of Chronic Kidney Disease in Rats. The American Journal of Physiology-Renal Physiology, 310, F857-F871.
https://doi.org/10.1152/ajprenal.00513.2015
|
[11]
|
Xu, K.Y., Xia, G.H., Lu, J.Q., Chen, M.X., Zhen, X., Wang, S., You, C., Nie, J., Zhou, H.W. and Yin, J. (2017) Impaired Renal Function and Dysbiosis of Gut Microbiota Contribute to Increased Trimethylamine-N-Oxide in Chronic Kidney Disease Patients. Scientific Reports, 7, Article No. 1445. https://doi.org/10.1038/s41598-017-01387-y
|
[12]
|
Jiang, S., Xie, S., Lv, D., Wang, P., He, H., Zhang, T., Zhou, Y., Lin, Q., Zhou, H., Jiang, J., et al. (2017) Alteration of the Gut Microbiota in Chinese Population with Chronic Kidney Disease. Scientific Reports, 7, Article No. 2870.
https://doi.org/10.1038/s41598-017-02989-2
|
[13]
|
Vaziri, N.D., Yuan, J., Nazertehrani, S., Ni, Z. and Liu, S. (2013) Chronic Kidney Disease Causes Disruption of Gastric and Small Intestinal Epithelial Tight Junction. American Journal of Nephrology, 38, 99-103.
https://doi.org/10.1159/000353764
|
[14]
|
Kanbay, M., Onal, E.M., Afsar, B., Dagel, T., Yerlikaya, A., Covic, A. and Vaziri, N.D. (2018) The Crosstalk of Gut Microbiota and Chronic Kidney Disease: Role of Inflammation, Pro-teinuria, Hypertension, and Diabetes Mellitus. International Urology and Nephrology, 50, 1453-1466. https://doi.org/10.1007/s11255-018-1873-2
|
[15]
|
Sabatino, A., Regolisti, G., Cosola, C., et al. (2017) Intestinal Mi-crobiota in Type 2 Diabetes and Chronic Kidney Isease. Current Diabetes Reports, 17, 16. https://doi.org/10.1007/s11892-017-0841-z
|
[16]
|
Tao, S., Li, L., Li, L., et al. (2019) Understanding the Gut-Kidney Axis among Biopsy-Proven Diabetic Nephropathy, Type 2 Diabetes Mellitus and Healthy Controls: An Analysis of the Gut Microbiota Composition. Acta Diabetologica, 56, 581-592. https://doi.org/10.1007/s00592-019-01316-7
|
[17]
|
Mazloom, K., Siddiqi, I. and Covasa, M. (2019) Probiotics: How Effective Are They in the Fight against Obesity? Nutrients, 11, 258. https://doi.org/10.3390/nu11020258
|
[18]
|
Lin, M.Y., de Zoete, M.R., van Putten, J.P., et al. (2015) Redirection of Epithelial Immune Responses by Short-Chain Fatty Acids through Inhibition of Histone Deacetylases. Frontiers in Immunology, 6, Article No. 554.
https://doi.org/10.3389/fimmu.2015.00554
|
[19]
|
Huang, W., Guo, H.L., Deng, X., et al. (2017) Short-Chain Fatty Acids Inhibit Oxidative Stress and Inflammation in Mesangial Cells Induced by High Glucose and Lipopolysaccharide. Experimental and Clinical Endocrinology & Diabetes, 125, 98-105. https://doi.org/10.1055/s-0042-121493
|
[20]
|
Mafifi, A., Namazi, G., Soleimani, A., Bahmani, F., Aghadavod, E. and Asemi, Z. (2018) Metabolic and Genetic Response to Probiotics Supplementation in Patients with Diabetic Nephrop-athy: A Randomized, Double-Blind, Placebo- Controlled Trial. Food & Function, 9, 4763-4770. https://doi.org/10.1039/C8FO00888D
|
[21]
|
Wang, H., Lu, Y., Yan, Y., et al. (2019) Promising Treatment for Type 2 Diabetes: Fecal Microbiota Transplantation Reverses Insulin Resistance and Impaired Islets. Frontiers in Cellular and Infection Microbiology, 9, Article No. 455.
https://doi.org/10.3389/fcimb.2019.00455
|
[22]
|
Sethi, J.K. and Vidal-Puig, A. (2005) Visfatin: The Missing Link between Intra-Abdominal Obesity and Diabetes? Trends in Molecular Medicine, 11, 344-347. https://doi.org/10.1016/j.molmed.2005.06.010
|
[23]
|
Chyl-Surdacka, K.M., Bartosinska, J., Kowal, M., et al. (2020) Assessment of Visfatin Concentrations in the Serum of Male Psoriatic Patients in Relation to Metabolic Abnormalities. Advances in Clinical and Experimental Medicine, 29, 79-84. https://doi.org/10.17219/acem/111820
|
[24]
|
Neubauer, K., Bednarz-Misa, I., Walecka-Zacharska, E., et al. (2019) Oversecretion and Overexpression of Nicotinamide Phos-phoribosyltransferase/Pre-B Colony-Enhancing Factor/Visfatin in Inflammatory Bowel Disease Reflects the Disease Ac-tivity, Severity of Inflammatory Response and Hypoxia. International Journal of Molecular Sciences, 20, 166. https://doi.org/10.3390/ijms20010166
|
[25]
|
Cheleschi, S., Tenti, S., Mondanelli, N., et al. (2021) MicroRNA-34a and MicroRNA-181a Mediate Visfatin-Induced Apoptosis and Oxidative Stress via NF-κB Pathway in Human Osteoar-thritic Chondrocytes. Cells, 8, 874.
https://doi.org/10.3390/cells8080874
|
[26]
|
沈寒蕾, 赖战峰, 谭晓丹, 邓宏明, 黄媛, 张峥嵘, 肖常青. 2型糖尿病患者血浆内脂素与炎症因子的相关性研究[J]. 中国现代医学杂志, 2012, 22(7): 44-47.
|
[27]
|
唐灵, 陈春莲, 苏桂兰, 刘树娇, 陈虹. 2型糖尿病肾病患者内脂素、脂联素和C反应蛋白变化及其临床意义[J]. 中国全科医学, 2011, 14(23): 2616-2619.
|
[28]
|
Kumari, B. and Yadav, U.C.S. (2018) Adipokine Visfatin’s Role in Pathogenesis of Di-abesity and Related Metabolic Derangements. Current Molecular Medicine, 18, 116-125. https://doi.org/10.2174/1566524018666180705114131
|
[29]
|
廖鑫, 邓凡曲, 杨丹, 等. 内脂素对大鼠成肌细胞PI3K/Akt信号通路及胰岛素敏感性影响的研究[J]. 中国糖尿病杂志, 2019, 27(9): 677-681.
|
[30]
|
Chow, F., Ozols, E., Nikolic-Paterson, D.J., et al. (2004) Macrophages in Mouse Type 2 Diabetic Nephropathy: Correlation with Diabetic State and Progressive Renal Injury. Kidney International, 65, 116-128.
https://doi.org/10.1111/j.1523-1755.2004.00367.x
|
[31]
|
Mahmoud, F. and Al-ozairi, E. (2013) Inflammatory Cyto-kines and the Risk of Cardiovascular Complications in Type 2. Diabetes, 35, 235-241. https://doi.org/10.1155/2013/931915
|
[32]
|
Giese, I.-M., Schilloks, M.-C., Degroote, R.L., et al. (2021) Chronic Hyperglycemia Drives Functional Impairment of Lymphocytes in Diabetic INSC94Y Transgenic Pigs. Frontiers in Im-munology, 11, Article ID: 607473.
https://doi.org/10.3389/fimmu.2020.607473
|
[33]
|
Moon, J.-Y., Jeong, K.-H., Lee, T.-W., et al. (2012) Aberrant Recruitment and Activation of T Cells in Diabetic Nephropathy. American Journal of Nephrology, 35, 164-174. https://doi.org/10.1159/000334928
|
[34]
|
Lim, A.K.H., Ma, F.Y., Nikolic-Paterson, D.J., et al. (2010) Lymphocytes Promote Albuminuria, But Not Renal Dysfunction or Histological Damage in a Mouse Model of Diabetic Renal Injury. Diabetologia, 53, 1772-1782.
https://doi.org/10.1007/s00125-010-1757-1
|
[35]
|
Kuriya, G., Uchida, T., Akazawa, S., et al. (2013) Double Defi-ciency in IL-17 and IFN-c Signalling Significantly Suppresses the Development of Diabetes in the NOD Mouse. Dia-betologia, 56, 1773-1780.
https://doi.org/10.1007/s00125-013-2935-8
|
[36]
|
Wu, C.-C., Chen, J.-S., Lu, K.-C., et al. (2010) Aberrant Cyto-kines/Chemokines Production Correlate with Proteinuria in Patients with Overt Diabetic Nephropathy. Clinica Chimica Acta, 411, 700-704.
https://doi.org/10.1016/j.cca.2010.01.036
|
[37]
|
Lampropoulou, I.T., Stangou, M., Sarafidis, P., et al. (2020) TNF-α Pathway and T-Cell Immunity Are Activated Early during the Development of Diabetic Nephropathy in Type II Diabetes Mellitus. Clinical Immunology, 215, Article ID: 108423. https://doi.org/10.1016/j.clim.2020.108423
|
[38]
|
Serreze, D.V., Fleming, S.A., Chapman, H.D., et al. (1998) B Lymphocytes Are Critical Antigen-Presenting Cells for the Initia-tion of T Cell-Mediated Autoimmune Diabetes in Nonobese Diabetic Mice. The Journal of Immunology, 161, 3912-3918.
|
[39]
|
Smith, M.J., Simmons, K.M. and Cambier, J.C. (2017) B Cells in Type 1 Diabetes Mellitus and Dia-betic Kidney Disease. Nature Reviews Nephrology, 13, 712-720. https://doi.org/10.1038/nrneph.2017.138
|